Veloxa XL Chewable Tablets for Dogs

Nchi: Uingereza

Lugha: Kiingereza

Chanzo: VMD (Veterinary Medicines Directorate)

Nunua Sasa

Shusha Tabia za bidhaa (SPC)
16-05-2024

Viambatanisho vya kazi:

Febantel, Praziquantel, Pyrantel

Inapatikana kutoka:

Lavet Pharmaceuticals Ltd

ATC kanuni:

QP52AA51

INN (Jina la Kimataifa):

Febantel, Praziquantel, Pyrantel

Dawa fomu:

Chewable tablet

Dawa ya aina:

NFA-VPS - Non-Food Animal – Veterinarian, Pharmacist, Suitably Qualified Person

Kundi la matibabu:

Dogs

Eneo la matibabu:

Anthelmintic

Idhini hali ya:

Authorized

Idhini ya tarehe:

2013-01-16

Tabia za bidhaa

                                Revised: June 2020
AN: 00084/2020
Page 1 of 6
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
VELOXA FORTE CHEWABLE TABLETS FOR DOGS
(in Greece and Hungary)
VELOXA 175/504/525 MG CHEWABLE TABLETS FOR DOGS
(in, Finland, Norway and Sweden)
VELOXA XL CHEWABLE TABLETS FOR DOGS
(in France, Ireland and United Kingdom)
ANTHELMEX FORTE CHEWABLE TABLETS FOR DOGS
(in Austria, Belgium, Germany, Luxembourg and the Netherlands)
HELM-EX CHEWABLE TABLETS FOR LARGE DOGS
(in Spain)
XINDEX FORTE CHEWABLE TABLETS FOR DOGS
(in Italy)
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each chewable tablet contains:
ACTIVE SUBSTANCES:
mg
Febantel
525.0
Pyrantel
175.0
(corresponding to Pyrantel embonate)
504.0
Praziquantel
175.0
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Chewable tablet.
Brownish, oval, divisible tablet. It can be divided into equal parts.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dogs.
Revised: June 2020
AN: 00084/2020
Page 2 of 6
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Anthelmintic for treatment of mixed infections by the following
roundworms and tapeworms
in dogs over 17.5 kg:
Ascarids :
Toxocara canis, Toxascaris leonina (adult and late immature forms)
Hookworms : Uncinaria stenocephala, Ancylostoma caninum (adults)
Whipworms : Trichuris vulpis (adults)
Tapeworms : Echinococcus spp. Taenia spp. and Dipylidium caninum
(adult and immature
forms).
4.3
CONTRAINDICATIONS
Do not use in animals with a known hypersensitivity to any of the
active substances or the
excipients. Please see also sections 4.7 and 4.8.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
Parasite resistance to any particular class of anthelmintic may
develop following frequent,
repeated use of an anthelmintic of that class.
Fleas serve as intermediate hosts for one common type of tapeworm –
_Dipylidium _
_caninum_.
Tapeworm infestation is certain to reoccur unless control of
intermediate hosts such as
fleas, mice, etc. is undertaken.
4.5
SPECIAL PRECAUTIONS FOR USE
Special precaution
                                
                                Soma hati kamili